An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 214, Issue suppl 3, Pages S342-S354
Publisher
Oxford University Press (OUP)
Online
2016-07-26
DOI
10.1093/infdis/jiw231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs
- (2016) Jared M. Odegard et al. VACCINE
- Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses
- (2015) Mallory Willet et al. JOURNAL OF INFECTIOUS DISEASES
- Stability of a Vesicular Stomatitis Virus–Vectored Ebola Vaccine
- (2015) Marianne Arnemo et al. JOURNAL OF INFECTIOUS DISEASES
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
- (2015) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Investigating the zoonotic origin of the West African Ebola epidemic
- (2014) A. Mari Saez et al. EMBO Molecular Medicine
- Ebola virus vaccines: an overview of current approaches
- (2014) Andrea Marzi et al. Expert Review of Vaccines
- Rhabdovirus-Based Vaccine Platforms against Henipaviruses
- (2014) Drishya Kurup et al. JOURNAL OF VIROLOGY
- Emergence of Zaire Ebola Virus Disease in Guinea
- (2014) Sylvain Baize et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
- (2014) S. K. Gire et al. SCIENCE
- An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
- (2013) Christopher B Fox et al. Expert Review of Vaccines
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
- (2013) John J. Treanor et al. VACCINE
- Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: Implication for post-exposure treatment
- (2013) Amy B. Papaneri et al. VACCINE
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines
- (2012) Christopher B. Fox et al. Clinical and Vaccine Immunology
- Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
- (2012) Amy B. Papaneri et al. VACCINE
- A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
- (2012) Amy B. Papaneri et al. VIROLOGY
- A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
- (2011) Austin Pantel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy
- (2011) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Prospects for immunisation against Marburg and Ebola viruses
- (2010) Thomas W. Geisbert et al. REVIEWS IN MEDICAL VIROLOGY
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
- (2010) Lisa E. Hensley et al. PLoS Pathogens
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- How Ebola Impacts Genetics of Western Lowland Gorilla Populations
- (2009) Pascaline J. Le Gouar et al. PLoS One
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
- (2008) Alexander Bukreyev et al. VIROLOGY
- Protection against lethal challenge by Ebola virus-like particles produced in insect cells
- (2008) Yuliang Sun et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now